Nathan W Furukawa

7PUBLICATIONS
7CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)CybercrimeClinical pharmacy and pharmacy practicePharmacogenomicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
A Turning Point for Hepatitis C Care: Point-of-Care Hepatitis C Virus RNA Authorization as a Critical First Step Toward Integrated Test-and-Treat Models in the United States.

Nathan W Furukawa, Saleem Kamili, Carolyn Wester

|Jul 15, 2025
Potential Impact of Frequent Testing for Hepatitis C Virus Among People Who Inject Drugs Toward Hepatitis C Elimination in the United States.

Lin Zhu, Nathan W Furukawa, William W Thompson

|Mar 01, 2021
Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.

Nathan W Furukawa, Mathew Weimer, Kara S Willenburg

|Sep 07, 2020
National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.

Nathan W Furukawa, Weiming Zhu, Ya-Lin A Huang

|Aug 05, 2020
Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018.

Nathan W Furukawa, Erin F Blau, Zach Reau

|Mar 21, 2020
Out-of-pocket costs and HIV pre-exposure prophylaxis persistence in a US multicity demonstration project.

Nathan W Furukawa, John A Schneider, Megan E Coleman

Pageof 2

Frequent Collaborators

1 joint publications

Ram K Shrestha

1 joint publications

Lin Zhu

1 joint publications

William W Thompson

1 joint publications

Marissa B Reitsma